BioCentury

BioCentury This Week

Science EN ↓ Epizody: 402

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

Určitě navštivte web podcastu a podpořte jeho tvůrce: www.biocentury.com

Autor

BioCentury

Kategorie

Science

Web podcastu

www.biocentury.com

Nejnovější epizoda

13. říj 2026

Kde poslouchat?

Podcasty v aplikaci Replaio Radio Už brzy

Podcasty míří do aplikace už brzy. Nainstaluj si ji teď a jako první uvidíš úplně nový pohled na podcasty

Nainstaluj zdarma Android téměř 10 mil. stažení · hodnocení 4,8 iOS už brzy

Epizody

Ep. 27 - CRISPR advances and mega-IPOs: a BioCentury podcast 13.10.2020 12:39

Reach us by sending a text

Ep. 26 - Treating Trump & BMS's $13B MyoKardia buy 06.10.2020 19:59

Reach us by sending a text

Ep. 25 - Alzheimer Milestones & Vaccine Politics 29.09.2020 13:23

Reach us by sending a text

Ep. 24 - Azar's Memo & Biotech's Deals 22.09.2020 17:01

Reach us by sending a text

Ep. 23 - $21B Deal by Gilead, None by PhRMA 15.09.2020 11:40

Reach us by sending a text

Ep. 22 - Back to School, Behind the Scenes 09.09.2020 16:41

Reach us by sending a text

Ep. 21 - FDA’s Credibility on the Line, plus Biotech’s Venture Wave 01.09.2020 11:27

Reach us by sending a text

Ep. 20 - Politics & Plasma 25.08.2020 15:05

Reach us by sending a text

Ep. 19 - I Want KaNDy, Plus Sputnik V & M&A amid COVID-19 17.08.2020 14:47

Reach us by sending a text

Ep. 18 - BIOEquality, Data Sharing and Deals 10.08.2020 17:04

Reach us by sending a text

Ep. 17 - Warp Speed, Decentralized Trials & SPACs 03.08.2020 16:18

Reach us by sending a text

Ep. 16 - Trump's Ultimatum, RADx & Preclinical IPOs 27.07.2020 18:05

Reach us by sending a text

Ep. 15 - Vaccine Hopes, the Shifting Biopharma Workplace & Blueprint's Dx Deal 21.07.2020 16:17

Reach us by sending a text

Ep. 14 - Investor Sentiment, HCQ Redux and Attacking AMR 14.07.2020 13:40

Reach us by sending a text

Ep. 13 - Nuances of NASH, COVID Vaccines and Real-World Data 06.07.2020 15:07

Reach us by sending a text

Ep. 12 - Remdesivir's Price, RWD’s Moment & A Genomics Breakup 29.06.2020 11:19

Reach us by sending a text

Ep. 11 - Funding U.K. Biotechs, plus Global Vaccine Access 23.06.2020 15:52

Reach us by sending a text

Ep. 10 - EUAs, ACTIV & M&A 16.06.2020 17:20

Reach us by sending a text

Ep. 9 - IPOs, Vaccines & BIO's New Leader 08.06.2020 13:49

Reach us by sending a text

Ep. 8 - Financing Flurry & Purchasing Pools 01.06.2020 13:14

Reach us by sending a text

Ep. 7 - FDA takes on COVID-19, plus ASCO's breakthroughs 27.05.2020 15:37

Reach us by sending a text

Ep. 6 - New Faces for COVID-19’s Next Phase, ASCO’s Hot Topics 19.05.2020 18:02

Reach us by sending a text

Ep. 5 - Master Protocols, EUAs and Rick Bright: BioCentury editors on COVID-19 12.05.2020 15:22

Reach us by sending a text

Ep. 4 - End of the beginning for vaccines and the post-pandemic future 05.05.2020 15:30

BioCentury editors discuss Goldilocks COVID-19 antibody test regulation, vaccine development, and the post-pandemic future. Reach us by sending a text

Ep. 3 - Surveying the Landscape for Biopharmas 28.04.2020 14:33

BioCentury Editors discuss what the latest survey results tell us about how biotechs are managing through the economic downturn, and cover what FDA Commissioner Hahn told BioCentury last week. Reach us by sending a text